This work is licensed under the Creative Commons Attribution 4.0 International License.
Masarone D, Kaski JP, Pacileo G, et al. Epidemiology and clinical aspects of genetic cardiomyopathies. Heart Fail Clin. 2018 Apr;14(2):119–128. doi: 10.1016/j.hfc.2017.12.007.MasaroneDKaskiJPPacileoGEpidemiology and clinical aspects of genetic cardiomyopathies. Heart Fail Clin. 2018Apr;14(2):119–128. doi: 10.1016/j.hfc.2017.12.007.Open DOISearch in Google Scholar
Soriano CJ, Ridocci F, Estornell J, et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol. 2005;45(5):743–748. doi: 10.1016/j.jacc.2004.11.037.SorianoCJRidocciFEstornellJNoninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol. 2005;45(5):743–748. doi: 10.1016/j.jacc.2004.11.037.Open DOISearch in Google Scholar
Lin LQ, Kazmirczak FE, Chen KH, et al. Impact of cardiovascular magnetic resonance imaging on identifying the etiology of cardiomyopathy in patients undergoing cardiac transplantation. Sci Rep. 2018;8:34648. doi: 10.1038/s41598-018-34648-5.LinLQKazmirczakFEChenKHImpact of cardiovascular magnetic resonance imaging on identifying the etiology of cardiomyopathy in patients undergoing cardiac transplantation. Sci Rep. 2018;8:34648. doi: 10.1038/s41598-018-34648-5.Open DOISearch in Google Scholar
Felker GM, Thompson RE, Hare JM, et al. Underlying causes and longterm survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084. doi: 10.1056/NEJM200004133421502.FelkerGMThompsonREHareJMUnderlying causes and longterm survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084. doi: 10.1056/NEJM200004133421502.Open DOISearch in Google Scholar
Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016;134(8). doi: 10.1161/CIR.0000000000000455.BozkurtBColvinMCookJCurrent diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016;134(8). doi: 10.1161/CIR.0000000000000455.Open DOISearch in Google Scholar
Kwong RY, Petersen SE, Schulz-Menger J, et al. The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): Its goals, rationale, data infrastructure, and current developments. J Cardiovasc Magn Reson. 2017;19(1):23. doi: 10.1186/s12968-016-0321-7.KwongRYPetersenSESchulz-MengerJThe global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): Its goals, rationale, data infrastructure, and current developments. J Cardiovasc Magn Reson. 2017;19(1):23. doi: 10.1186/s12968-016-0321-7.Open DOISearch in Google Scholar
Vermes E, Carbone I, Friedrich MG, et al. Patterns of myocardial late enhancement: Typical and atypical features. Arch Cardiovasc Dis. 2012;105(5):300–308. doi: 10.1016/j.acvd.2011.12.006.VermesECarboneIFriedrichMGPatterns of myocardial late enhancement: Typical and atypical features. Arch Cardiovasc Dis. 2012;105(5):300–308. doi: 10.1016/j.acvd.2011.12.006.Open DOISearch in Google Scholar
Doltra A, Amundsen BH, Gebker R, et al. Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev. 2013;9(3):185–190. doi: 10.2174/1573403X113099990030.DoltraAAmundsenBHGebkerREmerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev. 2013;9(3):185–190. doi: 10.2174/1573403X113099990030.Open DOISearch in Google Scholar
Satoh H, Sano M, Suwa K, et al. Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in the differential diagnosis, clinical features, and prognosis. World J Cardiol. 2014;6(7):585–601. doi: 10.4330/wjc.v6.i7.585.SatohHSanoMSuwaKDistribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in the differential diagnosis, clinical features, and prognosis. World J Cardiol. 2014;6(7):585–601. doi: 10.4330/wjc.v6.i7.585.Open DOISearch in Google Scholar
Franco A, Javidi S, Ruehm SG. Delayed myocardial enhancement in cardiac magnetic resonance imaging. J Radiol Case Rep. 2015;9(6):6–18. doi: 10.3941/jrcr.v9i6.2328.FrancoAJavidiSRuehmSG.Delayed myocardial enhancement in cardiac magnetic resonance imaging. J Radiol Case Rep. 2015;9(6):6–18. doi: 10.3941/jrcr.v9i6.2328.Open DOISearch in Google Scholar
Von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: A comprehensive summary and update. J Cardiovasc Magn Reson. 2023;25(1):42. doi: 10.1186/s12968-023-00950-z.Von Knobelsdorff-BrenkenhoffFSchulz-MengerJ.Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: A comprehensive summary and update. J Cardiovasc Magn Reson. 2023;25(1):42. doi: 10.1186/s12968-023-00950-z.Open DOISearch in Google Scholar
Arbelo E, Protonotarios A, Gimeno JR, et al. Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(37):3503–3626. doi: 10.1093/eurheartj/ehad194.ArbeloEProtonotariosAGimenoJRGuidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(37):3503–3626. doi: 10.1093/eurheartj/ehad194.Open DOISearch in Google Scholar
Puntmann VO, Valbuena S, Hinojar R, et al. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging end points in clinical research: Part I-analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018;20(1):67. doi: 10.1186/s12968-018-0484-5.PuntmannVOValbuenaSHinojarRSociety for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging end points in clinical research: Part I-analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018;20(1):67. doi: 10.1186/s12968-018-0484-5.Open DOISearch in Google Scholar
Patel AR, Kramer CM. Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1180–1193. doi: 10.1016/j.jcmg.2017.08.005.PatelARKramerCM.Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1180–1193. doi: 10.1016/j.jcmg.2017.08.005.Open DOISearch in Google Scholar
Kramer CM, Chandrashekhar Y. Multiparametric CMR in cardiomyopathies: Beyond diagnosis and toward prognosis. JACC Cardiovasc Imaging. 2019;12(8):1712–1714. doi: 10.1016/j.jcmg.2019.06.019.KramerCMChandrashekharY.Multiparametric CMR in cardiomyopathies: Beyond diagnosis and toward prognosis. JACC Cardiovasc Imaging. 2019;12(8):1712–1714. doi: 10.1016/j.jcmg.2019.06.019.Open DOISearch in Google Scholar
Kramer CM, Barkhausen J, Bucciarelli-Ducci C, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17. doi: 10.1186/s12968-020-00615-5.KramerCMBarkhausenJBucciarelli-DucciCStandardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17. doi: 10.1186/s12968-020-00615-5.Open DOISearch in Google Scholar
Hundley WE, Bluemke DA, Bogaert J, et al. Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2022;24(1):29. doi: 10.1186/s12968-021-00827-z.HundleyWEBluemkeDABogaertJSociety for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2022;24(1):29. doi: 10.1186/s12968-021-00827-z.Open DOISearch in Google Scholar
Popa O, Amzulescu M, Bugeac C, et al. Cardiovascular magnetic resonance imaging in myocardial disease. Cureus. 2024;16(4). doi: 10.7759/cureus.58688.PopaOAmzulescuMBugeacCCardiovascular magnetic resonance imaging in myocardial disease. Cureus. 2024;16(4). doi: 10.7759/cureus.58688.Open DOISearch in Google Scholar
Roifman I, Hammer M, Sparkes J, et al. Utilization and impact of cardiovascular magnetic resonance on patient management in heart failure: Insights from the SCMR registry. J Cardiovasc Magn Reson. 2022;24(1):65. doi: 10.1186/s12968-022-00890-0.RoifmanIHammerMSparkesJUtilization and impact of cardiovascular magnetic resonance on patient management in heart failure: Insights from the SCMR registry. J Cardiovasc Magn Reson. 2022;24(1):65. doi: 10.1186/s12968-022-00890-0.Open DOISearch in Google Scholar
Bruder O, Wagner A, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry — Multinational results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013;15:9. doi: 10.1186/1532-429X-15-9.BruderOWagnerALombardiMEuropean Cardiovascular Magnetic Resonance (EuroCMR) registry — Multinational results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013;15:9. doi: 10.1186/1532-429X-15-9.Open DOISearch in Google Scholar
Abbasi SA, Ertel A, Shah RV, et al. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson. 2013;15:89. doi: 10.1186/1532-429X-15-89.AbbasiSAErtelAShahRVImpact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson. 2013;15:89. doi: 10.1186/1532-429X-15-89.Open DOISearch in Google Scholar
Kanagala P, Cheng ASH, Singh A, et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction: Implications for clinical trials. J Cardiovasc Magn Reson. 2018;20(1):4. doi: 10.1186/s12968-017-0424-9.KanagalaPChengASHSinghADiagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction: Implications for clinical trials. J Cardiovasc Magn Reson. 2018;20(1):4. doi: 10.1186/s12968-017-0424-9.Open DOISearch in Google Scholar
Won E, Donnino R, Srichai MB, et al. Diagnostic accuracy of cardiac magnetic resonance imaging in the evaluation of newly diagnosed heart failure with reduced left ventricular ejection fraction. Am J Cardiol. 2015;116(7):1082–1087. doi: 10.1016/j.amjcard.2015.06.032.WonEDonninoRSrichaiMBDiagnostic accuracy of cardiac magnetic resonance imaging in the evaluation of newly diagnosed heart failure with reduced left ventricular ejection fraction. Am J Cardiol. 2015;116(7):1082–1087. doi: 10.1016/j.amjcard.2015.06.032.Open DOISearch in Google Scholar
Scatteia A, Dellegrottaglie S. Cardiac magnetic resonance in ischemic cardiomyopathy: Present role and future directions. Eur Heart J Suppl. 2023;25(Suppl C). doi: 10.1093/eurheartjsupp/suad007.ScatteiaADellegrottaglieS.Cardiac magnetic resonance in ischemic cardiomyopathy: Present role and future directions. Eur Heart J Suppl. 2023;25(Suppl C). doi: 10.1093/eurheartjsupp/suad007.Open DOISearch in Google Scholar
Rabbat MG, Kwong RY, Heitner JF, et al. The future of cardiac magnetic resonance clinical trials. JACC Cardiovasc Imaging. 2022;15(12):1967–1970. doi: 10.1016/j.jcmg.2021.07.029.RabbatMGKwongRYHeitnerJFThe future of cardiac magnetic resonance clinical trials. JACC Cardiovasc Imaging. 2022;15(12):1967–1970. doi: 10.1016/j.jcmg.2021.07.029.Open DOISearch in Google Scholar
Caforio ALP, Adler Y, Agostini C, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38(35):2649–2662. doi: 10.1093/eurheartj/ehx321.CaforioALPAdlerYAgostiniCDiagnosis and management of myocardial involvement in systemic immune-mediated diseases: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38(35):2649–2662. doi: 10.1093/eurheartj/ehx321.Open DOISearch in Google Scholar
Sado DM, Maestrini V, Piechnik SK, et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload: Myocardial T1 in iron overload. J Magn Reson Imaging. 2015;41(6):1505–1511. doi: 10.1002/jmri.24727.SadoDMMaestriniVPiechnikSKNoncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload: Myocardial T1 in iron overload. J Magn Reson Imaging. 2015;41(6):1505–1511. doi: 10.1002/jmri.24727.Open DOISearch in Google Scholar
Bruder O, Schneider S, Nothnagel D, et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: Results of the German pilot phase. J Am Coll Cardiol. 2009;54(15):1457–1466. doi: 10.1016/j.jacc.2009.07.003.BruderOSchneiderSNothnagelDEuroCMR (European Cardiovascular Magnetic Resonance) registry: Results of the German pilot phase. J Am Coll Cardiol. 2009;54(15):1457–1466. doi: 10.1016/j.jacc.2009.07.003.Open DOISearch in Google Scholar
Witek NO, Marczak M, Mazurkiewicz L, et al. Role of cardiac magnetic resonance in heart failure of initially unknown etiology: A 10-year observational study. Kardiol Pol. 2022;80(3):278–285. doi: 10.33963/KP.a2021.0186.WitekNOMarczakMMazurkiewiczLRole of cardiac magnetic resonance in heart failure of initially unknown etiology: A 10-year observational study. Kardiol Pol. 2022;80(3):278–285. doi: 10.33963/KP.a2021.0186.Open DOISearch in Google Scholar
Onciul S, Popa O-A, Nicolaescu R, et al. Stress perfusion CMR – A report of an initial Romanian experience. Rom J Cardiol. 2021;31(1):52–58. doi: 10.47803/rjc.2021.31.1.52.OnciulSPopaO-ANicolaescuRStress perfusion CMR – A report of an initial Romanian experience. Rom J Cardiol. 2021;31(1):52–58. doi: 10.47803/rjc.2021.31.1.52.Open DOISearch in Google Scholar